Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.

Source:http://linkedlifedata.com/resource/pubmed/id/20589317

Download in:

View as

General Info

PMID
20589317